Loading clinical trials...
Loading clinical trials...
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and common side effect of neurotoxic cancer treatment. The most frequent symptoms include sensory disturbances and weakness in the h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Universiteit Antwerpen
Collaborators
NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more
NCT06799351 · Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia, and more
NCT07319481 · Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT07279818 · Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT07169864 · Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), and more
Antwerp University Hospital
Edegem
University Hospital Leuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions